PLUS THERAPEUTICS, INC. - 8-K Filing
Plus Therapeutics held its annual stockholder meeting on May 14, 2026, where four proposals were voted on by shareholders representing 64,857,321 shares. Shareholders elected six directors with votes ranging from 11,863,579 to 12,417,138 in favor; ratified CBIZ CPAs as the independent auditor (60,860,051 for); approved executive compensation advisory vote (10,389,498 for); and approved a sixth amendment to its stock incentive plan (7,976,002 for). (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $PSTV